Back to
WOLVERINE TRADING, LLC
AMLX2 quarters
Position history for
WOLVERINE TRADING, LLC's holdings in AMYLYX PHARMACEUTICALS INC
No. Wolverine Trading exited its AMLX (Amylyx Pharmaceuticals) position in Q2 2024. Its Q1 2024 13F listed 11,571 shares worth $32,862. Wolverine Trading first reported AMLX in Q1 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$32,862
Total Shares Change
-11,571
Quarter-by-Quarter History
Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP